Motley Fool Asset Management LLC lifted its holdings in shares of GE HealthCare Technologies Inc. (NASDAQ:GEHC – Free Report) by 34.4% during the 4th quarter, according to its most recent disclosure with the SEC. The fund owned 42,370 shares of the company’s stock after purchasing an additional 10,854 shares during the period. Motley Fool Asset Management LLC’s holdings in GE HealthCare Technologies were worth $3,475,000 at the end of the most recent reporting period.
Several other large investors also recently made changes to their positions in GEHC. Norges Bank bought a new stake in shares of GE HealthCare Technologies during the fourth quarter worth $596,024,000. Capital Research Global Investors grew its holdings in shares of GE HealthCare Technologies by 25.0% during the third quarter. Capital Research Global Investors now owns 24,972,556 shares of the company’s stock worth $1,875,400,000 after purchasing an additional 4,998,154 shares during the last quarter. Dodge & Cox grew its holdings in shares of GE HealthCare Technologies by 16.8% during the third quarter. Dodge & Cox now owns 27,517,311 shares of the company’s stock worth $2,066,550,000 after purchasing an additional 3,949,361 shares during the last quarter. Boston Partners bought a new stake in shares of GE HealthCare Technologies during the third quarter worth $287,627,000. Finally, Temasek Holdings Private Ltd bought a new stake in shares of GE HealthCare Technologies during the third quarter worth $99,922,000. Institutional investors own 82.06% of the company’s stock.
Insider Transactions at GE HealthCare Technologies
In related news, insider Frank R. Jimenez bought 1,750 shares of the business’s stock in a transaction on Thursday, April 30th. The shares were purchased at an average price of $60.45 per share, with a total value of $105,787.50. Following the completion of the purchase, the insider owned 93,932 shares of the company’s stock, valued at $5,678,189.40. This represents a 1.90% increase in their position. The acquisition was disclosed in a legal filing with the SEC, which is available at this hyperlink. Also, Director Kevin Lobo bought 10,000 shares of the business’s stock in a transaction on Friday, May 22nd. The stock was bought at an average cost of $64.18 per share, for a total transaction of $641,800.00. Following the purchase, the director directly owned 14,363 shares of the company’s stock, valued at approximately $921,817.34. This trade represents a 229.20% increase in their position. The SEC filing for this purchase provides additional information. In the last ninety days, insiders have acquired 21,847 shares of company stock valued at $1,361,355. Corporate insiders own 0.36% of the company’s stock.
GE HealthCare Technologies Price Performance
GE HealthCare Technologies (NASDAQ:GEHC – Get Free Report) last posted its quarterly earnings results on Wednesday, April 29th. The company reported $0.99 earnings per share (EPS) for the quarter, missing the consensus estimate of $1.07 by ($0.08). GE HealthCare Technologies had a net margin of 9.10% and a return on equity of 20.46%. The firm had revenue of $5.13 billion during the quarter, compared to the consensus estimate of $5.04 billion. During the same quarter in the prior year, the business earned $1.01 EPS. GE HealthCare Technologies’s revenue was up 7.4% on a year-over-year basis. GE HealthCare Technologies has set its FY 2026 guidance at 4.800-5.000 EPS. As a group, research analysts anticipate that GE HealthCare Technologies Inc. will post 4.89 earnings per share for the current year.
Analyst Upgrades and Downgrades
GEHC has been the topic of several research analyst reports. Mizuho decreased their target price on GE HealthCare Technologies from $90.00 to $80.00 in a report on Thursday, April 30th. Weiss Ratings cut GE HealthCare Technologies from a “hold (c)” rating to a “hold (c-)” rating in a report on Friday, May 15th. Evercore set a $80.00 price target on GE HealthCare Technologies in a report on Thursday, April 30th. The Goldman Sachs Group reiterated a “neutral” rating on shares of GE HealthCare Technologies in a report on Monday. Finally, Argus decreased their price target on GE HealthCare Technologies from $95.00 to $80.00 and set a “buy” rating on the stock in a report on Tuesday, May 19th. Nine investment analysts have rated the stock with a Buy rating and nine have issued a Hold rating to the company. According to MarketBeat, the stock has an average rating of “Moderate Buy” and a consensus price target of $80.21.
Check Out Our Latest Stock Analysis on GE HealthCare Technologies
GE HealthCare Technologies Company Profile
GE HealthCare Technologies (NASDAQ: GEHC) is a global medical technology and diagnostics company that develops, manufactures and markets a broad range of products and services for healthcare providers. Its portfolio centers on diagnostic imaging systems, including MRI, CT, PET and X-ray modalities, as well as ultrasound equipment. The company also supplies patient monitoring and anesthesia delivery systems, interventional and surgical imaging solutions, and molecular imaging technologies used in both clinical care and research settings.
In addition to hardware, GE HealthCare offers software, analytics and lifecycle services aimed at improving clinical workflows and equipment uptime.
Featured Stories
- Five stocks we like better than GE HealthCare Technologies
- Everpure: AI Storage Uncertainty Overshadows Breakneck Growth
- This Tech ETF Is Beating QQQ—and Canada May Be Part of the Reason
- Intel Is the Market’s Most Mispriced AI Hedge
- The Biggest Opportunity From SpaceX’s IPO May Surprise You
Receive News & Ratings for GE HealthCare Technologies Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for GE HealthCare Technologies and related companies with MarketBeat.com's FREE daily email newsletter.
